Updates in melanoma: Treating BRAF and brain metastases

Source: eCancer TV, June 2017

Prof Georgina Long – University of Sydney, Sydney, Australia

Prof Long speaks with ecancer at ASCO 2017 about 5 year survival updates for BRAF melanoma patients treated with trametinib and dabrafenib.

She also reports on results from a trial of treating brain metastases with combined PD-1 and CTLA-4, reaching a PFS at 6 months of 47%.

Prof Long comments on the addition of radiotherapy to treat brain metastases, noting the work of Dr Ines Silva in establishing radionecrosis.

read the original full article

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories